Previously operating as a subsidiary of Solvay SA. Solvay Pharmaceuticals B.V. is a pharmaceutical and drugs company. Since February 2010, the firm has been a subsiduary of Abbott Laboratories. The firm develops, manufactures, and supplies pharmaceutical products. The company's products include cardio-metabolic for arrhythmia, cardio-metabolic disorders, congestive heart failure, hypertension, and obesity; neuroscience for anxiety and depression, psychosis, Parkinson's disease, and neurology; influenza vaccines for new delivery systems and adjuvant; pancreatic enzymes for bioengineered pancreatic enzymes; gastroenterology; and women's and men's health products. It offers fenofibrate, a cardio-metabolic product for treating raised blood lipids; and dyslipidemia products that control cholesterol and triglycerides. The company serves North America, Europe, the Middle East, Japan, Africa, the Asia Pacific, and Latin American markets. Abbott Products SA has strategic alliances with Bristol Myers Squibb, Wyeth Pharmaceuticals, Lundbeck, Petrovax, and Quintiles. Based in Brussels, Belgium the firm has additional locations in Victoriaville, Weesp/Olst, Neustadt, Chatillon, Dijon, Parets, Cork, Taboao, Mexico, NorthBrook; Weesp, Hanover, Dijon, Paris, Cork, Tokyo, and Atlanta. Solvay Pharmaceuticals, Inc. manufactures, markets and/or distributes more than 31 drugs in the United States.
